Figure 1.
Comparison of the postoperative OS rates of patients with HCC treated with liver-protection drugs only (control group) or with liver-protection drugs and cidan (treatment group). HCC, hepatocellular carcinoma; OS, overall survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.